Anavex Life Sciences Corp. (0HFR.L)
LSE - LSE Delayed price. Currency in USD
Add to watchlist
As of 03:31PM BST. Market open.
| Previous close | 11.59 |
| Open | 10.89 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's range | 10.89 - 10.89 |
| 52-week range | 10.89 - 10.89 |
| Volume | |
| Avg. volume | N/A |
| Market cap | 6.264M |
| Beta (5Y monthly) | 0.79 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.58 |
| Earnings date | 09 Aug 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Wall Street Analysts Think Anavex Life Sciences (AVXL) Could Surge 179%: Read This Before Placing a Bet
The average of price targets set by Wall Street analysts indicates a potential upside of 179.5% in Anavex Life Sciences (AVXL). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
- Zacks
Why Endo (ENDP) Stock Wilted After its Surge on Tuesday?
Endo International (ENDO) tanks 26%, cooling off after its massive stock price surge on Tuesday, post the Supreme Court's decision to overturn Roe v. Wade.
- Zacks
Global Blood (GBT) Initiates Phase II Study on SCD Candidate
Global Blood Therapeutics (GBT) initiates the phase II portion of its planned phase II/III studies on pipeline candidate GBT601 to identify the optimal dose for the pivotal phase III portion of the trial
© 2022 Yahoo. All rights reserved.
